Learning from the past: four pillars of clinical trial design
Although existing problems in clinical trial design have been intensified by COVID-19, the pandemic was not the root cause of these issues. Many trials are at risk due to design issues, resulting in costly protocol amendments and delays. At Phesi, we take a four pillars approach that lets sponsors tackle long-standing problems in trial design.
Bigger Patient Data, Better Results for Clients
This week we reached an important milestone with our collaborative partner Sensyne Health, achieving an anonymized dataset of over 60 million patients. Arming clients with data combining clinical research, clinical trial, and real-world patient records, we are now another step forward in reaching our goal to harness the power of real-time data to help clients accelerate the delivery of life-saving treatments to patients.
When will companies stop babysitting the nannis they hired for their clinical trials?
SCOPE continues to be a central location for industry colleagues to meet and exchange ideas around clinical development. We had a great time at the 2020 meeting catching up with friends, clients and colleagues, as well as co-moderating a roundtable on protocol design and chairing a main session on site selection with esteemed industry practitioners.
Less artificial…more intelligence
In the industry of clinical research, we are accustomed to working with conservative companies that make decisions slowly. Look at the adoption of EDC – over how many decades now? Understandable, at least to a point.